Correlation of the Ga-68-bombesin analog Ga-68-BZH3 with receptors expression in gliomas as measured by quantitative dynamic positron emission tomography (dPET) and gene arrays

Molecular Imaging and Biology

Volumn 14, Issue 3, 2012, Pages 376-383

  Strauss, Ludwig G ^a   Koczan, Dirk ^b   Seiz, Marcel ^c   Tuettenberg, Jochen ^d   Schmieder, Kirsten ^e   Pan, Leyun ^a   Cheng, Caixia ^a   Dimitrakopoulou Strauss, Antonia ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d Klinikum Idar Oberstein GmbH   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

BB 1; BB 2; BB 3; Bombesin subtype 3; Ga 68 bombesin; Gene array; Glioma; GRPR; Neuromedin B; PET

Indexed keywords

BOMBESIN RECEPTOR; BOMBESIN RECEPTOR SUBTYPE 3; GALLIUM BZH3 GA 68; GASTRIN RELEASING PEPTIDE RECEPTOR; MESSENGER RNA; NEUROMEDIN B; NEUROMEDIN B RECEPTOR; TRACER; UNCLASSIFIED DRUG;

ARTICLE; BLOOD VOLUME; CANCER GENETICS; CLINICAL ARTICLE; COMPARTMENT MODEL; CORRELATIONAL STUDY; DRUG RECEPTOR BINDING; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ANALYSIS; GLIOMA; HUMAN; HUMAN TISSUE; INTERNALIZATION; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECURRENT CANCER;

BOMBESIN; BRAIN NEOPLASMS; GALLIUM RADIOISOTOPES; GENE EXPRESSION PROFILING; GLIOMA; HUMANS; NONLINEAR DYNAMICS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POSITRON-EMISSION TOMOGRAPHY; RADIOACTIVE TRACERS; RECEPTORS, BOMBESIN; TISSUE ARRAY ANALYSIS;

EID: 84861482578     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-011-0508-0     Document Type: Article

References (26)

1. Strauss LG, Conti PS (1991) The applications of PET in clinical oncology. J Nucl Med 32:623-648
2. Strauss LG (1996) Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med Mol Imaging 23:1409-1415
3. Dimitrakopoulou-Strauss A, Strauss LG (2008) The role of 18F-FLT in cancer imaging: does it really reflect proliferation? Eur J Nucl Med Mol Imaging 35:523-526
4. Dimitrakopoulou-Strauss A, Georgoulias V, Eisenhut et al (2006) Quantitative assessment of SSTR2 expression in patients with nonsmall cell lung cancer using [68]Ga-DOTATOC PET and comparison with [18]F-FDG PET. Eur J Nucl Med Mol Imaging 33:823-830 (Pubitemid 43979691)
5. Koukouraki S, Strauss LG, Georgoulias V et al (2006) Evaluation of the pharmacokinetics of 68Ga-DOTATOC in patients with metastatic neuroendocrine tumors scheduled for 90Y-DOTATOC therapy. Eur J Nucl Med Mol Imaging 33:460-466
6. Schuhmacher J, Zhang H, Doll J et al (2005) GRP receptor-targeted PET of a rat pancreas carcinoma xenograft in nude mice with a (68)Galabeled Bombesin (6-14) analog. J Nucl Med 46:691-699 (Pubitemid 41721868)
7. Reubi JC, Wenger S, Schmuckli-Maurer J, Schaer JC, Gugger M (2002) Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE (14)] bombesin(6-14). Clin Cancer Res 8:1139-1146 (Pubitemid 35177367)
8. Pradhan TK, Katsuno T, Taylor JE, Kim SH, Ryan RR, Mantey SA, Donohue PJ, Weber HC, Sainz E, Battey JF, Coy DH, Jensen RT, Pradhan TK, Katsuno T, Taylor JE, Kim SH, Ryan RR, Mantey SA, Donohue PJ, Weber HC, Sainz E, Battey JF, Coy DH, Jensen RT (1998) Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes. Eur J Pharmacol 19(343):275-287 (Pubitemid 28138612)
9. Sharif TR, Luo W, Sharif M (1997) Functional expression of bombesin receptor in most adult and pediatric human glioblastoma cell lines; role in mitogenesis and in stimulating the mitogen-activated protein kinase pathway. Mol Cell Endocrinol 130:119-1130
10. Dimitrakopoulou-Strauss A, Seiz M, Tuettenberg J et al (2011) Pharmacokinetic studies of 68Ga-labeled Bombesin 68Ga-BZH3] and 18F-FDG PET in patients with recurrent gliomas and comparison to grading: preliminary results. Clin Nucl Med 36:101-108
11. Ohtake T, Kosaka N, Watanabe T, Yokoyama I, Moritan T, Masuo M et al (1991) Noninvasive method to obtain input function for measuring glucose utilization of thoracic and abdominal organs. J Nucl Med 32:1432-438
12. Strauss LG, Dimitrakopoulou-Strauss A, Koczan D et al (2004) 18F-FDG kinetics and gene expression in giant cell tumors. J Nucl Med 45:1528-1535 (Pubitemid 47618507)
13. Strauss LG, Koczan D, Klippel S et al (2008) Impact of angiogenesis-related gene expression on the tracer kinetics of 18F-FDG kinetics in colorectal tumors. J Nucl Med 49:1238-1244
14. Strauss LG, Pan L, Koczan D et al (2007) Fusion of positron emission tomography [PET] and gene array data: a new approach for the correlative analysis of molecular biological and clinical data. IEEE Transactions On Medical Imaging 26:804-812 (Pubitemid 46842915)
15. Bodei L, Pepe G, Paganelli G (2010) Peptide receptor radionuclide therapy [PRRT] of neuroendocrine tumors with somatostatin analogues. Eur Rev Med Pharmacol Sci 14:347-351
16. Hohla F, Schally AV (2010) Targeting gastrin releasing peptide receptors: New options for the therapy and diagnosis of cancer. Cell Cycle 9:1738-1741
17. Flores DG, Meurer L, Uberti AF et al (2010) Gastrin-releasing peptide receptor content in human glioma and normal brain. Brain Res Bull 82:95-98
18. Lockhart DJ, Winzeler EA (2000) Genomics, gene expression and DNA arrays. Nature 405:827-836 (Pubitemid 30407861)
19. Pascal LE, True LD, Campbell DS, Deutsch EW, Risk M, Coleman IM, Eichner LJ, Nelson PS, Liu AY (2008) Correlation of mRNA and protein levels: cell type-specific gene expression of cluster designation antigens in the prostate. BMC Genomics 23 (9):246
20. Tan CS, Salim A, Ploner A, Lehtiö J, Chia KS, Pawitan Y (2009) Correlating gene and protein expression data using Correlated Factor Analysis. BMC Bioinforma 10:272
21. de Oliveira MS, Cechim G, Braganhol E et al (2009) Anti-proliferative effect of the gastrin-release peptide receptor antagonist RC-3095 plus temozolomide in experimental glioblastoma models. J Neurooncol 93:191-201
22. Seiz M, Dimitrakopoulou-Strauss A, Schubert GA et al (2008) Differentiation between malignant transformation and tumour recurrence by [68]Ga-Bombesin and [18]F-FDG-PET, in patients with low grade gliomas. Hell J Nucl Med 11:149-152
23. Kang JH, Ishola TA, Baregamian N et al (2007) Bombesin induces angiogenesis and neuroblastoma growth. Cancer Lett 253:273-281 (Pubitemid 47017542)
24. Liu X, Carlisle DL, Swick MC, Gaither-Davis A, Grandis JR, Siegfried JM (2007) Gastrin-releasing peptide activates Akt through the epidermal growth factor receptor pathway and abrogates the effect of gefitinib. Exp Cell Res 15(313):1361-1372 (Pubitemid 46507449)
25. Scopinaro F, De Vincentis G, Corazziari E et al (2004) Detection of colon cancer with 99mTc-labeled bombesin derivative [99mTc-leu13-BN1]. Cancer Biother Radiopharm 19:245-252
26. Scopinaro F, De Vincentis G, Varvarigou AD et al (2003) 99mTc-bombesin detects prostate cancer and invasion of pelvic lymph nodes. Eur J Nucl Med Mol Imaging 30:1378-1382 (Pubitemid 37247955)